CSLScientist Fermentation & Cell Culture Development
Jan. 2017 - Aug. 2020Parkville, Victoria, AustraliaUpstream Bioprocessing development CHO cell lines - monoclonal antibodies and recombinant proteins Product pipeline projects: COVID-19, Anumigilimab (CSL324) Anti-G-CSFR mAb (HS), (CSL730) Recombinant Trivalent Human IgG1 Fc Multimer*, Trabikibart (CSL311) Anti-Beta Common mAb (Asthma), Factor VIIa (FVIIa)ย (CSL689), CSL040, Anti-VEGFB mAb (CSL346), Garadacimab anti-FXIIa monoclonal antibody (CSL312) Small scale and SUB large scale process development (fed- Batch Mode, draw fill)
Process characterization Scale up and Technical transfer
Project managment - representative for small scale bioreactor
Innovation
People's manager
Health and safety officer 4 years (including 1 external audit)